Teneligliptin hydrochloride is an oral medication used to treat type 2 diabetes. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors and is used to help control blood sugar levels, particularly when diet and exercise alone are not enough. It is grouped under the following drug class(es): DPP-4 inhibitors and Hypoglycemics. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Teneligliptin HCl and Tenelia. Its PubChem CID is 25022646.
Teneligliptin hydrochloride
| Molecular Formula | C22H31ClN6OS |
|---|---|
| Molecular Weight | 463.0 g/mol |
| Synonyms | [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Teneligliptin hydrochloride is an oral medication used to treat type 2 diabetes. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors and is used to help control blood sugar levels, particularly when diet and exercise alone are not enough.
The listed molecular formula is C22H31ClN6OS.
The listed molecular weight is 463.0 g/mol.
[(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone;hydrochloride.
The source lists Teneligliptin HCl and Tenelia.
It is listed under DPP-4 inhibitors and Hypoglycemics.